close

Rochester Medical Corporation develops, manufactures, and markets urinary continence and urine drainage care products for the extended care and acute care markets in Europe, the United States, and internationally. Its extended care products include a line of male external catheters for managing male urinary incontinence and a line of intermittent catheters for managing both male and female urinary retention. The company's extended care products also include Personal Catheters, a line of disposable intermittent catheters manufactured from silicone in three lengths with multiple diameters for male, female, and pediatric use; and the FemSoft Insert, a liquid-filled urethral insert for managing female stress urinary incontinence in adult females. Rochester's acute care products comprise a line of Foley catheters, including RELEASE-NF catheter, a silicone Foley catheter that reduces the incidence of hospital acquired urinary tract infection. The company offers silicone Foley catheters in a two-lumen version for urinary drainage management and in a three-lumen version that also supports irrigation of the urinary tract. It also provides antibacterial and hydrophilic intermittent catheters. In addition, the company manufactures and sells male external catheters made from proprietary non-latex and non-silicone material to certain private label customers, as well as markets two models of latex male external catheters. Rochester markets its products under the Rochester Medical brand name to distributors, extended care facilities, and individual hospitals and healthcare institutions through a direct sales force in the United States and the United Kingdom, and through independent distributors in other international markets. The company was founded in 1988 and is based in Stewartville, Minnesota.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	9.72
Volume	8346
Volume Avg	25847
52 Week High	11.84
52 Week Low	6.60
PE	N/A
PE (group average)	39
EPS Year	-0.11
EPS change Q/Q	-900%
EPS change Q/Q Yr ago	-233.33%
EPS change Q/Q next Q est	1000%
EPS change Y/Y	-22.22%
REV change Q/Q	18.35%
REV change Q/Q Yr ago	31.63%
EPS next Q est	0.05
EPS next Y est	0.76
Divident Annual	0.00
Dividend Yield	0%